Protein Tyrosine Phosphatases as Potential Regulators of STAT3 Signaling
Open Access
- 11 September 2018
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (9), 2708
- https://doi.org/10.3390/ijms19092708
Abstract
The signal transducer and activator of transcription 3 (STAT3) protein is a major transcription factor involved in many cellular processes, such as cell growth and proliferation, differentiation, migration, and cell death or cell apoptosis. It is activated in response to a variety of extracellular stimuli including cytokines and growth factors. The aberrant activation of STAT3 contributes to several human diseases, particularly cancer. Consequently, STAT3-mediated signaling continues to be extensively studied in order to identify potential targets for the development of new and more effective clinical therapeutics. STAT3 activation can be regulated, either positively or negatively, by different posttranslational mechanisms including serine or tyrosine phosphorylation/dephosphorylation, acetylation, or demethylation. One of the major mechanisms that negatively regulates STAT3 activation is dephosphorylation of the tyrosine residue essential for its activation by protein tyrosine phosphatases (PTPs). There are seven PTPs that have been shown to dephosphorylate STAT3 and, thereby, regulate STAT3 signaling: PTP receptor-type D (PTPRD), PTP receptor-type T (PTPRT), PTP receptor-type K (PTPRK), Src homology region 2 (SH-2) domain-containing phosphatase 1(SHP1), SH-2 domain-containing phosphatase 2 (SHP2), MEG2/PTP non-receptor type 9 (PTPN9), and T-cell PTP (TC-PTP)/PTP non-receptor type 2 (PTPN2). These regulators have great potential as targets for the development of more effective therapies against human disease, including cancer.Keywords
Funding Information
- National Institute of Environmental Health Sciences (ES022250)
This publication has 148 references indexed in Scilit:
- Tumor Derived Mutations of Protein Tyrosine Phosphatase Receptor Type K Affect Its Function and Alter Sensitivity to Chemotherapeutics in GliomaPLOS ONE, 2013
- Ptpn11/Shp2 Acts as a Tumor Suppressor in Hepatocellular CarcinogenesisCancer Cell, 2011
- Crystal structure of human protein tyrosine phosphatase SHP-1 in the open conformationJournal of Cellular Biochemistry, 2011
- Phosphotyrosine Signaling: Evolving a New Cellular Communication SystemCell, 2010
- Synapse formation regulated by protein tyrosine phosphatase receptor T through interaction with cell adhesion molecules and FynThe EMBO Journal, 2009
- Tumor Suppression by Phospholipase C-β3 via SHP-1-Mediated Dephosphorylation of Stat5Cancer Cell, 2009
- Tyrosine phosphorylation: thirty years and countingCurrent Opinion in Cell Biology, 2009
- Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesisMolecular Carcinogenesis, 2007
- Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysisGenes, Chromosomes and Cancer, 2007
- Differential activities in adhesion and neurite growth of fibronectin type III repeats in the PTP-δ extracellular domainInternational Journal of Developmental Neuroscience, 2006